Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 32 holding rows worth $703,730,000.

Accession
0001085146-22-001109
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 32 entries on the cover page, a total value of $703,730,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $703,730,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM2,075,402$286,011,000thousands by filing date
QUIDEL CORP74838J101COM855,068$115,426,000thousands by filing date
OPKO HEALTH INC68375N103COM12,219,073$58,774,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM861,008$36,050,000thousands by filing date
AGENUS INC00847G705COM NEW9,106,132$29,322,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,420,652$29,120,000thousands by filing date
Pfizer Inc.717081103COM475,000$28,049,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,670,733$23,140,000thousands by filing date
Accelerate Diagnostics00430H102COM3,627,549$18,936,000thousands by filing date
Pfizer Inc.717081103COM1,400,000$15,041,000thousands by filing dateput
FORIAN INC34630N106cs1,219,661$11,001,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM5,547,094$9,818,000thousands by filing date
DERMTECH INC24984K105COM602,907$9,526,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM659,191$7,343,000thousands by filing date
ANTARES PHARMA INC036642106COM1,720,000$6,140,000thousands by filing date
CONTRAFECT CORP212326300COM1,952,422$5,135,000thousands by filing date
IMMUTEP LTD45257L108SPONSORED ADS976,156$3,202,000thousands by filing date
CROSS CTRY HEALTHCARE INC227483104COM71,000$1,971,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM287,600$1,577,000thousands by filing dateput
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock700,000$1,383,000thousands by filing dateput
SPY78462F103SHS500,000$1,308,000thousands by filing dateput
ARK ETF TR00214Q302GENOMIC REV ETF350,000$1,076,000thousands by filing dateput
SOLENO THERAPEUTIVS, INC.834203200COMM2,132,000$874,000thousands by filing date
OPKO HEALTH INC68375N103COM757,300$685,000thousands by filing dateput
XBIOTECH INC98400H102COM500,000$674,000thousands by filing dateput
BIOGEN INC COM09062X103Stock2,412$579,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock416,300$531,000thousands by filing dateput
DERMTECH INC24984K105COM250,000$425,000thousands by filing dateput
PROTAGENIC THERAPEUTICS INC74365N103COM300,267$416,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock67,000$126,000thousands by filing dateput
MOTUS GI HLDGS INC62014P108COM105,885$49,000thousands by filing date
AGENUS INC00847G705COM NEW298,300$22,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-22-001109this filing2022-02-14acceptance time not in the bulk data set